FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Brewer

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Brewer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: George J Brewer
Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 2012;26(2-3):89-92.
2012: George J Brewer
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease.
BioFactors (Oxford, England) 2012;38(2):107-13.
2011: George J Brewer
Issues raised involving the copper hypotheses in the causation of Alzheimer's disease.
International journal of Alzheimer's disease 2011;2011():537528.
2010: George J Brewer; Steve H Kanzer; Earl A Zimmerman; Eric S Molho; Dzintra F Celmins; Susan M Heckman; Robert Dick
Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease.
American journal of Alzheimer's disease and other dementias 2010;25(7):572-5.
2010: George J Brewer; Steve H Kanzer; Earl A Zimmerman; Dzintra F Celmins; Susan M Heckman; Robert Dick
Copper and ceruloplasmin abnormalities in Alzheimer's disease.
American journal of Alzheimer's disease and other dementias 2010;25(6):490-7.
2010: George J Brewer
Toxicity of copper in drinking water.
Journal of toxicology and environmental health. Part B, Critical reviews 2010;13(6):449-52; author reply 453-9.
2010: George J Brewer
Copper toxicity in the general population.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2010;121(4):459-60.
2010: Frederick K Askari; Dawna Innis; Robert B Dick; Guoqing Hou; Jorge A Marrero; Joel K Greenson; George J Brewer
Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial.
Translational research : the journal of laboratory and clinical medicine 2010;155(3):123-30.
2010: George J Brewer
Risks of copper and iron toxicity during aging in humans.
Chemical research in toxicology 2010;23(2):319-26.
2009: George J Brewer
Drug development for orphan diseases in the context of personalized medicine.
Translational research : the journal of laboratory and clinical medicine 2009;154(6):314-22.
2009: George J Brewer; Frederick K Askari; Robert B Dick; Julia Sitterly; John K Fink; Martha D Carlson; Karen J Kluin; Matthew T Lorincz
Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
Translational research : the journal of laboratory and clinical medicine 2009;154(2):70-7.
2009: George J Brewer
The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease.
Journal of the American College of Nutrition 2009;28(3):238-42.
2009: Guoqing Hou; Robert Dick; George J Brewer
Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
Experimental biology and medicine (Maywood, N.J.) 2009;234(6):662-5.
2009: Sara J Tallaksen-Greene; Anita Janiszewska; Kasha Benton; Guoqing Hou; Robert Dick; George J Brewer; Roger L Albin
Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
Neuroscience letters 2009;452(1):60-2.
2009: George J Brewer
Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
Metallomics : integrated biometal science 2009;1(3):199-206.
2009: George J Brewer
The use of copper-lowering therapy with tetrathiomolybdate in medicine.
Expert opinion on investigational drugs 2009;18(1):89-97.
2008: George J Brewer; John Althaus
How reliable and robust are current biomarkers for copper status?--comments by Brewer and Althaus.
The British journal of nutrition 2008;100(6):1341-2; discussion 1343-4.
2008: Guoqing Hou; Gerald D Abrams; Robert Dick; George J Brewer
Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
Translational research : the journal of laboratory and clinical medicine 2008;152(5):239-44.
2008: George J Brewer
The risks of free copper in the body and the development of useful anticopper drugs.
Current opinion in clinical nutrition and metabolic care 2008;11(6):727-32.
2008: Chunhua Zeng; Guoqing Hou; Robert Dick; George J Brewer
Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
Experimental biology and medicine (Maywood, N.J.) 2008;233(8):1021-5.
2008: George J Brewer
Causes and diagnosis of copper deficiency.
American journal of hematology 2008;83(1):87-8.
2007: George J Brewer
A brand new mechanism for copper toxicity.
Journal of hepatology 2007;47(4):621-2.
2007: Guoqing Hou; Robert Dick; Chunhua Zeng; George J Brewer
Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
Translational research : the journal of laboratory and clinical medicine 2007;149(5):260-4.
2007: George J Brewer
Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease.
Experimental biology and medicine (Maywood, N.J.) 2007;232(2):323-35.
2006: Guoqing Hou; Robert Dick; Chunhua Zeng; George J Brewer
Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Translational research : the journal of laboratory and clinical medicine 2006;148(6):309-14.
2006: Mark D McCubbin; Guoqing Hou; Gerald D Abrams; Robert Dick; Zhan Zhang; George J Brewer
Tetrathiomolybdate is effective in a mouse model of arthritis.
The Journal of rheumatology 2006;33(12):2501-6.
2006: George J Brewer
Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2006;54(6):291-302.
2006: George J Brewer; Robert Dick; Chunhua Zeng; Guoqing Hou
The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
Journal of inorganic biochemistry 2006;100(5-6):927-30.
2006: George J Brewer; Frederick K Askari; Matthew T Lorincz; Martha D Carlson; Michael Schilsky; Karen J Kluin; Peter Hedera; Paolo Moretti; John K Fink; Roberta Tankanow; Robert B Dick; Julia Sitterly
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
Archives of neurology 2006;63(4):521-7.
2006: Arjmand R Mufti; Ezra Burstein; Rebecca A Csomos; Paul C F Graf; John C Wilkinson; Robert D Dick; Madhavi Challa; Jae-Kyoung Son; Shawn B Bratton; Grace L Su; George J Brewer; Ursula Jakob; Colin S Duckett
XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders.
Molecular cell 2006;21(6):775-85.
2006: George J Brewer
Novel therapeutic approaches to the treatment of Wilson's disease.
Expert opinion on pharmacotherapy 2006;7(3):317-24.
2005: Vicki L Goodman; George J Brewer; Sofia D Merajver
Control of copper status for cancer therapy.
Current cancer drug targets 2005;5(7):543-9.
2005: Guoqing Hou; Robert Dick; Gerald D Abrams; George J Brewer
Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
The Journal of laboratory and clinical medicine 2005;146(5):299-303.
2005: George J Brewer
Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Drug discovery today 2005;10(16):1103-9.
2005: George J Brewer
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.
Current cancer drug targets 2005;5(3):195-202.
2005: George J Brewer
Behavioral abnormalities in Wilson's disease.
Advances in neurology 2005;96():262-74.
2005: George J Brewer; Frederick K Askari
Wilson's disease: clinical management and therapy.
Journal of hepatology 2005;42 Suppl(1):S13-21.
2005: George J Brewer
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
CNS drugs 2005;19(3):185-92.
2005: Susan G Elner; Victor M Elner; Ayako Yoshida; Robert D Dick; George J Brewer
Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Investigative ophthalmology & visual science 2005;46(1):299-303.
2004: George J Brewer; Robert Dick; Matt Ullenbruch; Hong Jin; Sem H Phan
Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Journal of inorganic biochemistry 2004;98(12):2160-7.
2004: Frederick K Askari; Robert Dick; Maria Mao; George J Brewer
Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.
Experimental biology and medicine (Maywood, N.J.) 2004;229(8):857-63.
2004: V L Goodman; George J Brewer; Sofia D Merajver
Copper deficiency as an anti-cancer strategy.
Endocrine-related cancer 2004;11(2):255-63.
2004: Ezra Burstein; Lakshmanan Ganesh; Robert D Dick; Bart van De Sluis; John C Wilkinson; Leo W J Klomp; Cisca Wijmenga; George J Brewer; Gary Nabel; Colin S Duckett
A novel role for XIAP in copper homeostasis through regulation of MURR1.
The EMBO journal 2004;23(1):244-54.
2004: Martha D Carlson; Majeed Al-Mateen; George J Brewer
Atypical childhood Wilson's disease.
Pediatric neurology 2004;30(1):57-60.
2003: Frederick K Askari; Joel K Greenson; Robert D Dick; Virginia D Johnson; George J Brewer
Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
The Journal of laboratory and clinical medicine 2003;142(6):385-90.
2003: Peter Hedera; John K Fink; Paula L Bockenstedt; George J Brewer
Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome.
Archives of neurology 2003;60(9):1303-6.
2003: Quintin Pan; Li Wei Bao; Celina G Kleer; George J Brewer; Sofia D Merajver
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.
Molecular cancer therapeutics 2003;2(7):617-22.
2003: Claudell Cox; Sofia D Merajver; Sirius Yoo; Robert D Dick; George J Brewer; Julia Shin-Jung Lee; Theodoros N Teknos
Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model.
Archives of otolaryngology--head & neck surgery 2003;129(7):781-5.
2003: Bruce G Redman; Peg Esper; Quintin Pan; Rodney L Dunn; Hero Hussain; Thomas L Chenevert; George J Brewer; Sofia D Merajver
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1666-72.
2003: George J Brewer
Copper in medicine.
Current opinion in chemical biology 2003;7(2):207-12.
2003: George J Brewer; Peter Hedera; Karen J Kluin; Martha D Carlson; Frederick K Askari; Robert B Dick; Julia Sitterly; John K Fink
Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.
Archives of neurology 2003;60(3):379-85.
2003: George J Brewer; Matt Ullenbruch; Robert Dick; Leovigildo Olivarez; Sem H Phan
Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
The Journal of laboratory and clinical medicine 2003;141(3):210-6.
2003: George J Brewer
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
Journal of cellular and molecular medicine 2003;7(1):11-20.
2002: George J Brewer; Sofia D Merajver
Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Integrative cancer therapies 2002;1(4):327-37.
2002: Quintin Pan; Celina G Kleer; Kenneth L van Golen; Jennifer Irani; Kristen M Bottema; Carlos Bias; Magda De Carvalho; Enrique Mesri; Diane M Robins; Robert D Dick; George J Brewer; Sofia D Merajver
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Cancer research 2002;62(17):4854-9.
2002: Kenneth L van Golen; LiWei Bao; George J Brewer; Kenneth J Pienta; Jeffrey M Kamradt; Donna L Livant; Sofia D Merajver
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.
Neoplasia (New York, N.Y.) 2002;4(5):373-9.
2002: Peter Hedera; George J Brewer; John K Fink
White matter changes in Wilson disease.
Archives of neurology 2002;59(5):866-7.
2002: Dr. Muhammad Khan; Meredith W Miller; Jeremy Taylor; Navkiranjit K Gill; Robert D Dick; Kenneth L van Golen; George J Brewer; Sofia D Merajver
Radiotherapy and antiangiogenic TM in lung cancer.
Neoplasia (New York, N.Y.) 2002;4(2):164-70.
2002: Andrew K Vine; George J Brewer
Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Transactions of the American Ophthalmological Society 2002;100():73-6; discussion 76-7.
2001: L Olivarez; Michele Caggana; Kenneth A Pass; P Ferguson; George J Brewer
Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach.
Annals of human genetics 2001;65(Pt 5):459-63.
2001: George J Brewer
Zinc acetate for the treatment of Wilson's disease.
Expert opinion on pharmacotherapy 2001;2(9):1473-7.
2001: George J Brewer
Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease.
Experimental biology and medicine (Maywood, N.J.) 2001;226(7):665-73.
2001: Claudell Cox; Theodoros N Teknos; M Barrios; George J Brewer; Robert D Dick; Sofia D Merajver
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.
The Laryngoscope 2001;111(4 Pt 1):696-701.
2001: George J Brewer; Robert D Dick; Virginia D Johnson; John K Fink; Karen J Kluin; S Daniels
Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
The Journal of laboratory and clinical medicine 2001;137(3):191-8.
2000: George J Brewer; Virginia D Johnson; Robert D Dick; Peter Hedera; John K Fink; Karen J Kluin
Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Hepatology (Baltimore, Md.) 2000;31(2):364-70.
2000: George J Brewer; Robert D Dick; D K Grover; V LeClaire; M Tseng; Max S Wicha; Kenneth J Pienta; Bruce G Redman; Thierry jahan; vernon sondak; Myla S Strawderman; Gerald L LeCarpentier; Sofia D Merajver
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):1-10.
2000: George J Brewer
Recognition, diagnosis, and management of Wilson's disease.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 2000;223(1):39-46.
1999: George J Brewer
Penicillamine should not be used as initial therapy in Wilson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(4):551-4.
1999: George J Brewer; John K Fink; Peter Hedera
Diagnosis and treatment of Wilson's disease.
Seminars in neurology 1999;19(3):261-70.
1999: George J Brewer
The treatment of Wilson's disease.
Advances in experimental medicine and biology 1999;448():115-26.
1998: George J Brewer; Robert D Dick; Virginia D Johnson; James A Brunberg; Karen J Kluin; John K Fink
Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
The Journal of laboratory and clinical medicine 1998;132(4):264-78.
1998: George J Brewer
Wilson disease and canine copper toxicosis.
The American journal of clinical nutrition 1998;67(5 Suppl):1087S-1090S.
1997: George J Brewer; V Johnson; Joseph Kaplan
Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function.
The Journal of laboratory and clinical medicine 1997;129(6):649-52.
1996: B Esmaeli; Michael A Burnstine; C L Martonyi; Alan Sugar; V Johnson; George J Brewer
Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease.
Cornea 1996;15(6):582-8.
1996: George J Brewer; V Johnson; R D Dick; Karen J Kluin; John K Fink; James A Brunberg
Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy.
Archives of neurology 1996;53(10):1017-25.
1995: George J Brewer
Practical recommendations and new therapies for Wilson's disease.
Drugs 1995;50(2):240-9.
1995: George J Brewer
Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
Nutrition (Burbank, Los Angeles County, Calif.) 1995;11(1 Suppl):114-6.
1994: George J Brewer; R D Dick; Vilma Yuzbasiyan-Gurkan; V Johnson; Y Wang
Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
The Journal of laboratory and clinical medicine 1994;123(6):849-58.
1994: George J Brewer; R D Dick; V Johnson; Y Wang; Vilma Yuzbasiyan-Gurkan; Karen J Kluin; John K Fink; A Aisen
Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.
Archives of neurology 1994;51(6):545-54.
1994: George J Brewer; A Turkay; V Yuzbaziyan-Gurkan
Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine.
Archives of neurology 1994;51(3):304-5.
1993: Linda M Selwa; C W Vanderzant; James A Brunberg; George J Brewer; Ivo Drury; Ahmad Beydoun
Correlation of evoked potential and MRI findings in Wilson's disease.
Neurology 1993;43(10):2059-64.
1993: George J Brewer; Vilma Yuzbasiyan-Gurkan; R Dick; Y Wang; V Johnson
Does a vegetarian diet control Wilson's disease?
Journal of the American College of Nutrition 1993;12(5):527-30.
1993: George J Brewer; Vilma Yuzbasiyan-Gurkan; V Johnson; R D Dick; Y Wang
Treatment of Wilson's disease with zinc XII: dose regimen requirements.
The American journal of the medical sciences 1993;305(4):199-202.
1993: George J Brewer; Vilma Yuzbasiyan-Gurkan; V Johnson; R D Dick; Y Wang
Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.
Journal of the American College of Nutrition 1993;12(1):26-30.
1992: Vilma Yuzbasiyan-Gurkan; A Grider; Timothy T Nostrant; Robert J Cousins; George J Brewer
Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
The Journal of laboratory and clinical medicine 1992;120(3):380-6.
1992: George J Brewer; R D Dick; W Schall; Vilma Yuzbasiyan-Gurkan; Thomas P Mullaney; C Pace; J Lindgren; M Thomas; G Padgett
Use of zinc acetate to treat copper toxicosis in dogs.
Journal of the American Veterinary Medical Association 1992;201(4):564-8.
1992: George J Brewer; Vilma Yuzbasiyan-Gurkan
Wilson disease.
Medicine 1992;71(3):139-64.
1992: George J Brewer; W Schall; R Dick; Vilma Yuzbasiyan-Gurkan; M Thomas; G Padgett
Use of 64copper measurements to diagnose canine copper toxicosis.
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 1992;6(1):41-3.
1991: George J Brewer; Vilma Yuzbasiyan-Gurkan; V Johnson
Treatment of Wilson's disease with zinc. IX: Response of serum lipids.
The Journal of laboratory and clinical medicine 1991;118(5):466-70.
1991: Vilma Yuzbasiyan-Gurkan; V Johnson; George J Brewer
Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis.
The Journal of laboratory and clinical medicine 1991;118(5):458-65.
1991: P R Kollros; R D Dick; George J Brewer
Correction of cerebrospinal fluid copper in Menkes kinky hair disease.
Pediatric neurology 1991;7(4):305-7.
1991: George J Brewer; R D Dick; V Yuzbasiyan-Gurkin; R Tankanow; Anne B Young; Karen J Kluin
Initial therapy of patients with Wilson's disease with tetrathiomolybdate.
Archives of neurology 1991;48(1):42-7.
1991: M Akil; J A Schwartz; D Dutchak; Vilma Yuzbasiyan-Gurkan; George J Brewer
The psychiatric presentations of Wilson's disease.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(4):377-82.
1990: George J Brewer; Vilma Yuzbasiyan-Gurkan; D Y Lee
Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.
Journal of the American College of Nutrition 1990;9(5):487-91.
1990: H H Lee; G M Hill; V K Sikha; George J Brewer; Ananda S Prasad; Chung Owyang
Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease.
The Journal of laboratory and clinical medicine 1990;116(3):283-8.
1989: D Y Lee; George J Brewer; Y X Wang
Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.
The Journal of laboratory and clinical medicine 1989;114(6):639-45.
1989: George J Brewer; Vilma Yuzbasiyan-Gurkan; D Y Lee; Henry D Appelman
Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
The Journal of laboratory and clinical medicine 1989;114(6):633-8.
1989: Vilma Yuzbasiyan-Gurkan; George J Brewer; G D Abrams; B Main; Donald Giacherio
Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease.
The Journal of laboratory and clinical medicine 1989;114(5):520-6.
1989: George J Brewer; Vilma Yuzbasiyan-Gurkan
Wilson's disease: an update, with emphasis on new approaches to treatment.
Digestive diseases (Basel, Switzerland) 1989;7(4):178-93.
1988: Vilma Yuzbasiyan-Gurkan; George J Brewer; E Boerwinkle; Patrick J Venta
Linkage of the Wilson disease gene to chromosome 13 in North-American pedigrees.
American journal of human genetics 1988;42(6):825-9.
1988: V Iyengar; George J Brewer; R D Dick; O Y Chung
Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
The Journal of laboratory and clinical medicine 1988;111(3):267-74.
1988: K A Menerey; W Eider; George J Brewer; E M Braunstein; H R Schumacher; I H Fox
The arthropathy of Wilson's disease: clinical and pathologic features.
The Journal of rheumatology 1988;15(2):331-7.
1987: George J Brewer; Vilma Yuzbasiyan-Gurkan; Anne B Young
Treatment of Wilson's disease.
Seminars in neurology 1987;7(2):209-20.